FDG Avidity at PET/CT During Adjuvant Hormonal Therapy in Patients With Breast Cancer.

CONCLUSIONS: In our series, FDG PET/CT shows a similar diagnostic accuracy in detecting disease relapse between patients with BC on adjuvant HT versus those who have completed therapy. These preliminary results suggest that the glucose metabolism is not altered by hormonal suppression at the time of the scan.
PMID: 24398430 [PubMed - in process]

Source: Clinical Breast Cancer - January 15, 2014 Category: Cancer & Oncology Authors: Evangelista L, Redana S, Racca M, Geuna E, Vinante L, Zago G, De Carolis V, Ghiotto C, Saladini G, Varetto T Tags: Clin Nucl Med Source Type: research